F-Star Therapeutics, Inc.

FSTXCIK 0001566373 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Sep 9, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at F-Star Therapeutics, Inc.

Name	Roles	Filings
Brewis Neil	Officer	3
Deptula-Hicks Darlene M	Officer	3
Forster Eliot	OfficerDirector	3
Kayitalire Louis	Officer	3
Race Geoffrey	Director	3

Showing 1-5 of 10

Per pagePage 1 of 2Next

All filings

25 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 9, 2023	Brady Todd C Director	UTender	15,004	$7.12	$106,828
Mar 9, 2023	Deptula-Hicks Darlene M See Remarks	UTender	30,898	$7.12	$219,994
Mar 9, 2023	Klein Pamela M. Director	Holdings only	-	-	-
Mar 9, 2023	Forster Eliot PRESIDENT AND CEO · Director	UTender	347,578	$7.12	$2,474,755
Mar 9, 2023	Kayitalire Louis CHIEF MEDICAL OFFICER	UTender	29,236	$7.12	$208,160

Showing 6-10 of 25

Per pagePrevPage 2 of 5Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value